Online first
Clinical vignette
Published online: 2025-03-31
Pseudothyrotoxicosis in multiple myeloma
Abstract
Not required for Clinical Vignette.
Keywords: pseudothyrotoxicosisGraves’ diseasemultiple myelomathyroid function testmonoclonal antibodiesM proteins
References
- Ram N, Furqan S, Ahmed S. Is It T3 Thyrotoxicosis? A Case of Falsely Elevated Tri-Iodothyronine (T3) Levels Leading to a Diagnosis of Multiple Myeloma. Case Rep Endocrinol. 2019; 2019: 5028534.
- Cissewski K, Faix JD, Reinwein D, et al. Factitious hyperthyroxinemia due to a monoclonal IgA in a case of multiple myeloma. Clin Chem. 1993; 39(8): 1739–1742.
- Mandal K, Ashorobi D, Lee A, et al. Factitiously Elevated Total Triiodothyronine in a Euthyroid Patient with Multiple Myeloma. Case Rep Endocrinol. 2021; 2021: 8479193.
- Antonopoulou M, Silverberg A. Spurious t3 thyrotoxicosis unmasking multiple myeloma. Case Rep Endocrinol. 2013; 2013: 739302.
- Pan Q, Zhang Y, Zhang W, et al. The Prevalence of Euthyroid Hypertriiodothyroninemia in Newly Diagnosed Multiple Myeloma and its Clinical Characteristics. Endocr Pract. 2021; 27(3): 236–240.
